References
- AduraMIMejiasAKatzKS2007Daptomycin therapy for invasive gram-positive bacterial infections in childrenPediatr Infect Dis J2611283218043450
- AtkinsRLHaaseMRLevyEN2006Pharmacokinetics of daptomycin in a critically ill adolescent with vancomycin-resistant enterococcal endocarditisPharmacotherapy26694816715610
- Abdel-RahmanSMBenzigerDPJacobsRF2008Single-dose pharmacokinetics of daptomycin in children with suspected or proven gram-positive infectionsPediatr Infect Dis J27330418316988
- Cohen-WolkowiezMSmithPBBenjaminDK2008Daptomycin use in infants: report of two cases with peak and trough drug concentrationsJournal of Perinatology28233418309318
- MurrayBE2000Vancomycin-resistant enterococcal infectionsN Engl J Med3427102110706902
- MatsumuraSOLouieLLouieM1999Synergy testing of Vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combinations with other antimicrobial agentsAugment Altern Commun4327769
- OberholzerCACasertaMT2005Antimicrobial update: daptomycinPediatr Infect Dis J249192016220092
- SaimanL2003Endocarditis and intravascular infectionsLongSPickeringLProberCPrinciples and Practices of Pediatric Infectious Diseases2nd edPhiladelphiaChurchill Livingston253
- SchrieverCAFernandezKARodvoldKA2005Daptomycin: a novel cyclic lipopeptide antimicrobialAm J Health Syst Pharm6211455815914875
- TissieresPGervaixABeghettiM2003Value and limitations of the vonReyn, Duke, and modified Duke criteria for the diagnosis of endocarditis in childrenPediatrics11246771
- Torres-VieraCDembryL-M2004Approaches to vancomycin-resistant enterococciCurr Opin Infect Dis17541715640708